69 related articles for article (PubMed ID: 17488414)
21. The use and value of procalcitonin in solid organ transplantation.
Sandkovsky U; Kalil AC; Florescu DF
Clin Transplant; 2015 Aug; 29(8):689-96. PubMed ID: 25996831
[TBL] [Abstract][Full Text] [Related]
22. Procalcitonin does discriminate between sepsis and systemic inflammatory response syndrome.
Arkader R; Troster EJ; Lopes MR; Júnior RR; Carcillo JA; Leone C; Okay TS
Arch Dis Child; 2006 Feb; 91(2):117-20. PubMed ID: 16326799
[TBL] [Abstract][Full Text] [Related]
23. Antithymocyte globulin induction therapy adjusted for immunologic risk after heart transplantation.
Czer LS; Phan A; Ruzza A; Rafiei M; Setareh-Shenas S; Caceres M; Awad M; Soliman C; Mirocha J; De Robertis M; Kass RM; Trento A
Transplant Proc; 2013; 45(6):2393-8. PubMed ID: 23953554
[TBL] [Abstract][Full Text] [Related]
24. Early increase of procalcitonin after cardiovascular surgery in patients with postoperative complications.
Meisner M; Rauschmayer C; Schmidt J; Feyrer R; Cesnjevar R; Bredle D; Tschaikowsky K
Intensive Care Med; 2002 Aug; 28(8):1094-102. PubMed ID: 12185431
[TBL] [Abstract][Full Text] [Related]
25. [Role of procalcitonin in the diagnosis of uncomplicated infective endocarditis].
Hryniewiecki T; Sitkiewicz D; Rawczyńska-Englert I
Przegl Lek; 2002; 59(10):793-5. PubMed ID: 12632914
[TBL] [Abstract][Full Text] [Related]
26. [Diagnostic value of some markers of infection in cardiosurgical patients in the early postoperative period].
Beloborodova NV; Popov DA
Anesteziol Reanimatol; 2005; (3):45-9. PubMed ID: 16076047
[TBL] [Abstract][Full Text] [Related]
27. The use of procalcitonin determinations in evaluation of systemic lupus erythematosus.
Quintana G; Medina YF; Rojas C; Fernandez A; Restrepo JF; Rondon F; Iglesias A
J Clin Rheumatol; 2008 Jun; 14(3):138-42. PubMed ID: 18525431
[TBL] [Abstract][Full Text] [Related]
28. Serum procalcitonin in uncomplicated falciparum malaria: a preliminary study.
Uzzan B; Izri A; Durand R; Deniau M; Bouchaud O; Perret GY
Travel Med Infect Dis; 2006 Mar; 4(2):77-80. PubMed ID: 16887728
[TBL] [Abstract][Full Text] [Related]
29. Detection of procalcitonin (PCT) in healthy controls and patients with local infection by a sensitive ILMA.
Morgenthaler NG; Struck J; Fischer-Schulz C; Seidel-Mueller E; Beier W; Bergmann A
Clin Lab; 2002; 48(5-6):263-70. PubMed ID: 12071576
[TBL] [Abstract][Full Text] [Related]
30. Procalcitonin serum concentration during Pneumocystis jiroveci colonization or Pseudomonas aeruginosa infection/colonization in lung transplant recipients.
Zeglen S; Wojarski J; Wozniak-Grygiel E; Siola M; Szewczyk M; Kucewicz-Czech E; Nozynski J; Zembala M
Transplant Proc; 2009 Oct; 41(8):3225-7. PubMed ID: 19857716
[TBL] [Abstract][Full Text] [Related]
31. Prospective evaluation of procalcitonin in adults with febrile neutropenia after haematopoietic stem cell transplantation.
Ortega M; Rovira M; Filella X; Almela M; Puig de la Bellacasa J; Carreras E; Mensa J
Br J Haematol; 2004 Aug; 126(3):372-6. PubMed ID: 15257709
[TBL] [Abstract][Full Text] [Related]
32. Procalcitonin is a valuable prognostic marker in cardiac surgery but not specific for infection.
Dörge H; Schöndube FA; Dörge P; Seipelt R; Voss M; Messmer BJ
Thorac Cardiovasc Surg; 2003 Dec; 51(6):322-6. PubMed ID: 14669128
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic accuracy of serum procalcitonin concentrations for detecting systemic bacterial infection in patients with systemic autoimmune diseases.
Tamaki K; Kogata Y; Sugiyama D; Nakazawa T; Hatachi S; Kageyama G; Nishimura K; Morinobu A; Kumagai S
J Rheumatol; 2008 Jan; 35(1):114-9. PubMed ID: 18050369
[TBL] [Abstract][Full Text] [Related]
34. Combination treatment of low dose Anti-Thymocyte Globulin (ATG), Rituximab and high dose Sirolimus as induction agents in immune-conditioned recipients.
Ravichandran P; Natrajan T; Jaganathan R
Int Immunopharmacol; 2006 Dec; 6(13-14):1973-6. PubMed ID: 17161350
[TBL] [Abstract][Full Text] [Related]
35. Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients.
Meisner M; Adina H; Schmidt J
Crit Care; 2006 Feb; 10(1):R1. PubMed ID: 16356205
[TBL] [Abstract][Full Text] [Related]
36. Induction therapy including antithymocyte globulin induces marked alterations in T lymphocyte subpopulations after liver transplantation: results of a long-term study.
Oertel M; Sack U; Kohlhaw K; Lehmann I; Emmrich F; Berr F; Hauss J; Schwarz R
Transpl Int; 2002 Oct; 15(9-10):463-71. PubMed ID: 12389078
[TBL] [Abstract][Full Text] [Related]
37. Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation.
Bonaros N; Dunkler D; Kocher A; Imhof M; Grimm M; Zuckermann A; Wolner E; Laufer G
J Heart Lung Transplant; 2006 Sep; 25(9):1154-63. PubMed ID: 16962480
[TBL] [Abstract][Full Text] [Related]
38. The value of procalcitonin as an infection marker in cardiac surgery.
Baykut D; Schulte-Herbrüggen J; Krian A
Eur J Med Res; 2000 Dec; 5(12):530-6. PubMed ID: 11147997
[TBL] [Abstract][Full Text] [Related]
39. Procalcitonin Kinetics After Heart Transplantation and as a Marker of Infection in Early Postoperative Course.
Nadziakiewicz P; Grochla M; Krauchuk A; Pióro A; Szyguła-Jurkiewicz B; Baca A; Zembala MO; Przybyłowski P
Transplant Proc; 2020 Sep; 52(7):2087-2090. PubMed ID: 32305202
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of C-reactive protein, interleukin-6, and procalcitonin levels in allogeneic hematopoietic stem cell recipients.
Pihusch M; Pihusch R; Fraunberger P; Pihusch V; Andreesen R; Kolb HJ; Holler E
Eur J Haematol; 2006 Feb; 76(2):93-101. PubMed ID: 16405429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
